Form 4: Arteris CEO Charles Janac Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Arteris CEO Charles Janac sold a total of 65,509 shares of common stock in two transactions on December 13th and 16th, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- Arteris, Inc. CEO Charles Janac executed two sales of common stock on December 13th and December 16th, 2024.
- The first sale on December 13th involved 59,247 shares at a weighted average price of $10.3115, with individual prices ranging from $10.00 to $10.60.
- The second sale on December 16th involved 6,262 shares at a weighted average price of $10.117, with individual prices ranging from $10.00 to $10.28.
- These transactions were conducted under a 10b5-1 trading plan adopted by Mr. Janac on February 27, 2024.
- Following these sales, Mr. Janac directly owns 274,776 shares and indirectly owns 10,221,926 shares through Bayview Legacy, LLC and 77,286 shares through the Charles and Lydia Janac Trust.
Sentiment
Score: 5
Explanation: The document is neutral as it reports routine stock sales under a pre-arranged plan. There is no indication of positive or negative sentiment.
Risks
- Sales by a company's CEO could be perceived negatively by the market, potentially impacting the stock price.
Industry Context
Insider trading activity is a common occurrence in publicly traded companies, and these transactions are often scrutinized by investors and regulators. The use of a 10b5-1 trading plan is a common way for insiders to sell shares while avoiding accusations of trading on non-public information.
Comparison to Industry Standards
- The use of 10b5-1 trading plans is a standard practice for executives at publicly traded companies like Arteris, similar to practices at companies such as Cadence Design Systems (CDNS) and Synopsys (SNPS).
- These plans allow for scheduled sales of stock to avoid any appearance of insider trading, which is a common concern for executives with access to material non-public information.
- The reported sales are within the typical range of insider transactions, and the price ranges are consistent with the stock's trading activity.
Stakeholder Impact
- The stock sales by the CEO could potentially cause a slight negative reaction from shareholders, although the use of a 10b5-1 plan mitigates this risk.
Key Dates
| Date | Description |
|---|---|
| 2024-02-27 | Date the 10b5-1 trading plan was adopted by Charles Janac. |
| 2024-12-13 | Date of the first stock sale transaction. |
| 2024-12-16 | Date of the second stock sale transaction. |
| 2024-12-17 | Date the Form 4 was signed. |
Keywords
Arteris, Charles Janac, insider trading, stock sale, 10b5-1 plan, CEO, AIP, Bayview Legacy LLC, share transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.